Novo NordiskSee all their emails

Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved

A real announcement email from Novo Nordisk. Captured July 15, 2026.

Make this email yours

Migma AI designs one like it with your logo, colors, and images.

Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved email from Novo Nordisk screenshot

Captured Announcement

Novo Nordisk announces European Commission approval for the Wegovy pill for weight management.

Minimalist corporate layout with a top-aligned logo, bulleted highlights, and a long-form press release text structure. No prominent CTA buttons, focusing on information dissemination.

Original email and brand assets belong to their respective owners. Design notes describe the creative, not campaign results.